1-Phenyl-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-benzimidazole>98.0%(GC)(T)1g

5-Hidroximetilfurfural, mínimo 97 %, para síntesis, 250 mg, envase de vidrio

2-Ethyl-5-methylfuran, 95+%, 250mg

2-(4-Trifluoromethoxyphenyl)malondialdehyde, 97.0%, 1g

6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine, 95.0%, 1g

2-AMINO-2-(2,4-DIFLUOROPHENYL)ACETIC ACID HCL, 95.0%, 5g

2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide, 98.0%, 25g

1-Heptadecyne>97.0%(GC)1g

3-Bromo-6-methoxypyrazolo[1,5-a]pyridine, 97.0%, 1g

2-Bromodibenzo[b,d]thiophene, 95.0%, 100g

6-Fluorooxindole, 99.0%, 25g

8-(TRIFLUOROMETHOXY)QUINOLIN-3-OL, 95%, 100mg

2-(2-(2-(2-(4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethoxy)ethoxy)ethanol dihydrochloride, 97%, 250mg